© Reuters. A bundle of PlanB One-Step, an emergency contraceptive tablet, is seen in safety packaging at a CVS Pharmacy in Washington, U.S., July 7, 2022. REUTERS/Sarah Silbiger
(Reuters) -Personal fairness traders of Basis Shopper Healthcare, which sells widespread morning-after tablet Plan B One-Step, are exploring a possible sale of the corporate, Bloomberg Information reported on Wednesday.
The corporate might search greater than $4 billion, the report mentioned, citing folks accustomed to the matter.
Stakeholders, together with Kelso & Co. and Juggernaut Capital Companions, are working with monetary advisers and are at an early stage of deliberations, which can or might not end in a deal, the report mentioned.
The privately-held firm, which makes over-the-counter healthcare merchandise, purchased Plan B One-Step and different manufacturers of emergency contraception from Israel-based Teva Pharmaceutical Industries (NYSE:) in 2017 for $675 million in money.
Kelso, Juggernaut and Basis Shopper Healthcare didn’t instantly reply to Reuters requests for remark.
